MatTek Life Sciences

MatTek Life Sciences is a global leader in advanced in vitro technology, specializing in the development of 3D reconstructed human tissue models. The company's portfolio includes skin, ocular, oral, respiratory, and intestinal tissue models used as alternatives to animal testing for safety and efficacy evaluations. MatTek serves the pharmaceutical, cosmetics, and chemical industries by providing high-quality primary cells, culture media, and contract testing services. Their proprietary technology allows for more accurate human-relevant data in the early stages of product development. The company was acquired by BICO Group in 2021, integrating its capabilities into a larger bio-convergence ecosystem. MatTek continues to be a key player in the movement toward non-animal testing methods and regulatory-accepted in vitro assays.